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Orthosiphon aristatus (Lamiaceae) is an herb medicinal found mainly in China, Indian and South East 
Asia. The purpose of this work was to develop a technological process for obtaining dry extract of 
Orthosiphon aristatus by spray dry. A process for the obtaining of dry extract from aqueous extract of 
Orthosiphon aristatus was studied. Response Surface Methodology experimental design was applied 
to evaluate the effects of inlet and outlet air temperature on drying yield (%). Mixture experimental 
design was applied to evaluate the drying adjuvant - total solids relation. Maltodextrin was evaluated 
as drying adjuvant. The best results were obtained when applying an inlet temperature of 120 °C and 
outlet temperature of 80 °C and a drying adjuvant - total solids relation (w/w) of 60:40. Under these 
conditions it was demonstrated that the process is reproducible scale studied.
Keywords: Orthosiphon aristatus/extract. Spray dry/process. Drying adjuvant. Reflux method. 
Experimental design.
INTRODUCTION
Orthosiphon aristatus (Lamiaceae) is an herb 
medicinal found mainly in China, Indian and South East 
Asia (Suddee, Paton, Parnell, 2005). In Cuba, this species 
was introduced in the 70’s of the last century. Its useful 
part is the foliage which is used as a dry drug and fluid 
extract (Robaina Mesa, Rodriguez-Chanfrau, Nogueira 
Mendonza, 2016), and its oral administration. Preclinical 
studies showed the diuretic effect of aqueous extract. 
Furthermore, it has been reported that the average effective 
dose was 200 mg / kg for the aqueous extract. While the 
acute oral toxicity study showed that doses of 2000 mg / 
kg not cause toxicity (León-Padilla et al., 1996; Ramos 
Ruiz, Villaescusa Gonzalez, Vizoso Parra, 1996).
In the last decade, the industrial manufacturing of 
phytomedicine has grown considerably (Couto et al., 
2011). Because of this, transforming a natural raw material 
into a product suitable for industrial use and further 
therapeutic application it has become a necessity. Several 
studies on Orthosiphon aristatus have been reported. 
However, no studies on the preparation dry extract by 
spray dry have been reported. The purpose of this work 
was to develop a technological process for obtaining dry 
extract of Orthosiphon aristatus by spray dry.
MATERIALS AND METHODS
Vegetal material
Orthosiphon aristatus Blume from the Experimental 
Station of Medicinal Plants Dr Juan Tomas Roig (Artemisa 
province, Cuba) was collected (Cuba, 1983; 1992). 
Herbarium specimens, voucher ROIG 4632, have been 
deposited in herbaria at the Experimental Station. The 
plant material was dried in a solar dryer (SEC SOL-4 
equipment, Cuba) for 72 h and grinded (MANESTY 
equipment, Italia) to smaller particle size of 100 μm.
Obtaining concentrated aqueous extracts
Figure 1 show the procedure used in obtaining 
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concentrated aqueous extracts. Stainless steel reactor 
(stirred tank type) 20 L capacity, marine propeller stirrer 
and heating system and gas extraction was used. Solvent 
drug ratio 1:20 (w/v) and volume 10 L was used. The 
extract was filtered under vacuum and concentrated until 
total solids greater than 10%. Three batches were prepared 
and evaluated according to the technique of quality 
control. (Rodríguez-Chanfrau, Castellano, 2012).
Technological development process
Establishment of drying parameters
Response Surface Methodology (RSM) with a 32 
central composed experimental design replicated in the 
center point (Statgraphics plus 5.1, USA) was applied 
to evaluate the effects of inlet air temperature (X1) and 
outlet air temperature (X2) on drying yield (%). The coded 
independent variables used are listed in Table I. The levels 
of independent parameters were based on preliminary 
experimental results. Nine experiments were performed. 
The concentrated aqueous extracts were drying in a 
Buchi B 191 model spray dryer (Switzerland). Inter and 
outlet air temperatures were carried out according to the 
experimental design. The product was fed into the spray 
dryer at room temperature 600 L/h; the rate was varied to 
regulated exit air temperature at the desired value. The 
powder in plastic bags was placed.
Establishment of the concentration of drying 
adjuvant
Due to the adhesion of the product on the wall of 
the chamber was necessary to use 10 DE Maltodextrin 
(Arancia-cpc, Mexico) as drying adjuvant. Mixture design 
was studied. Five experiences with the following drying 
adjuvant - total solids relation: 0.9: 0.1; 0.6: 0.4; 0.5: 0.5; 
0.3: 0.7 and 0 1.0 were evaluated. The carried solution 
was prepared by dissolving the drying adjuvant in 1 L 
of aqueous extract under constant stirring before spray 
drying. The concentrated aqueous extracts under similar 
conditions to that described above were spray dried.
Drying efficiency was assessed by determining 
the total powder content obtained in the process and 
comparing it with the theoretical powder content that 
can be obtained. Three batches (10 L scale) with the 
inert additive were prepared and drying efficiency was 
determined.
Statistical analysis
Experimental design, data analysis and optimization 
procedure were performed using Statgraphic plus 5.1 
(USA). Results were considered significant when p<0.05.
RESULTS
Table II shows the results of the characterization of 
the concentrated aqueous extracts batch. In all cases dark, 
transparent liquid amber was obtained. The process yields 
were above 85%.
Figure 2 show the Pareto chart for the response 
variable. A significant influence of the dryer temperatures 
was observed (p= 0,0018 y p= 0,0466 for inlet air 
temperature and outlet air temperature, respectively). The 
best yields (75,2 ± 0,00) were obtained at 120 °C and 80 
°C for inter air temperature and outlet air temperature, 
respectively. The relationship between the two variables 
does not significantly influence (p=0.0837). This behavior 
is described by the following model equation: 
FIGURE 1 - Technological process diagram.
TABLE I - Code levels of independent variables used in the 
response surface methodology design
Independent 
variables
Coded levels
Low Medium High
X1 100 140 160
X2 60 80 100
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Yields (%) = 71,99 – 16,44 X1 + 10,41 X2 
(r = 0,98; r2 = 0,97).
As can be seen in Table III, the best yields were 
attained with a maltodextrin – total solid ration between 
0,6 and 0,9. In this range significant differences were not 
observed. The yields obtained are consistent with the scale 
of work used (bench scale).
Three batches (10 L scale) with a maltodextrin – 
total solid ration of 60:40 were prepared. Yields above 
89% were obtained. In this condition, a significant 
difference was not observed (Table IV). 
DISCUSSION
The preparation of intermediary products from 
medicinal plant is an important part of the development 
of pharmaceutical solid dosage form (Couto et al., 2011; 
Leuenberger, Lanz, 2005; Muzzio, Shinbot, Glasser, 
2002). These allow the safety and efficacy of medicinal 
products derived from natural sources is guaranteed. 
TABLE II - Analytical results from the batch of aqueous extracts
Assay Results Quality limits
Batch 1 2 3
Relative density 0,992 0,995 0,992 Between 0,990 and 
1,050
Total solids 8,6 9,4 8,8 Minimum 8,0%
pH 5,5 5,4 5,5 Between 5,0 and 6,0
Microbial count CT: 100 
CH: <10
CT: 1000 
CH: <10
CT: 100 
CH: <10
TC: 104 CFU/g 
HC: 103 CFU /g 
Absence of pathogens
FIGURE 2 - Pareto chart.
TABLE III - Study results drying adjuvant - total solids relation 
(Similar letter no significant for p<0.05)
Drying adjuvant - total solids 
relation (w/w) Yield (%)
0,9:0,1 90,9 a
0,6:0,4 91,8 a
0,5:0,5 89,3 b
0,3:0,7 83,6 c
0:1,0 75,2 d
TABLE IV - Results of spray dried product (Similar letter no 
significant for p<0.05)
Batch Yield (%)
1 90,3 a
2 89,5 a
3 91,2 a
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These are made from plant extract containing metabolites 
of interest. Transforming an herbal raw material into a 
product suitable for industrial is a complex operation 
requiring the use of various technological processes, 
including the drying of plant extract (Couto et al., 2011). 
At present, one of the techniques used in the drying of 
the extract is spray dry due to operational flexibility and 
affordable cost (Wendel, Celik, 1987). 
Spray dried powder has high stability being 
easy handling and storage. However, may present the 
disadvantages of being excessively fine, light, poor, or 
deficient in flow properties and compressibility (Couto 
et al., 2011). In many cases, the presence of sugars in the 
extract causes adhesion of the product on the wall of the 
chamber during the drying process. 
Similar problems were observed in this study. The 
temperatures set on the experimental design allowed for 
a rapid drying of the extract without affecting its chemical 
quality. But, product loss was observed by adhesion to the 
walls of the chamber. Because of these yields were low. 
This situation means that yields are low during the 
drying process. A solution is to use drying adjuvants, which 
also serve as excipients of pharmaceutical formulation. 
Excipients are responsible for modifying the physical and 
chemical properties of a pharmaceutical formulation and 
must be safe for oral administration (Couto et al., 2011). 
The possibility of excipient addition in the extract feed is 
the main factor responsible for the use of spray dry spray 
for drying extracts obtained from natural sources (Couto 
et al., 2011; Broadhead, Rouan, Rhodes, 1992).
On the basis that the main objective of this work 
was to develop a drying process extract of Orthosiphon 
aristatus extract for later elaboration of solid dosage 
forms, and knowing that to dry the extract was necessary 
to use adjuvant drying, it was decided to use maltodextrin 
as drying adjuvant. This excipient is included in the Food 
and Drug Administration´s Inactive Ingredients Guide, is 
approved for oral tablets, and capsules (Rowe, Sheskey, 
Owen, 2004).
As can be see the best yields was obtained when 
maltodextrin- total solids ratio was 60:40. In this condition, 
fine dry powder brown color was obtained. Yields are 
considered good for the scale in which we worked. 
In worked scale, no significant differences between 
batches produced were observed. This result demonstrates 
that the batches are homogeneous. It also demonstrates the 
reproducibility of the technology developed.
CONCLUSION
In conclusion, the best results were obtained 
when applying an inlet temperature of 120 °C and 
outlet temperature of 80 °C and a drying adjuvant - total 
solids relation (w/w). Under these conditions, it was 
demonstrated that the process is reproducible scale studied.
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